Short Interest in Moolec Science SA (NASDAQ:MLEC) Expands By 128.4%

Moolec Science SA (NASDAQ:MLEC) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 20,742 shares, an increase of 128.4% from the May 31st total of 9,082 shares. Based on an average daily volume of 37,357 shares, the days-to-cover ratio is presently 0.6 days. Approximately 3.6% of the shares of the stock are short sold.

Moolec Science Trading Down 9.1%

NASDAQ MLEC traded down $0.74 on Tuesday, reaching $7.35. 9,455 shares of the company were exchanged, compared to its average volume of 810,440. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79. The business’s fifty day moving average price is $7.91 and its 200 day moving average price is $7.59. The stock has a market capitalization of $5.37 million, a P/E ratio of -0.22 and a beta of 0.28. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $100.20.

Moolec Science (NASDAQ:MLEC) last issued its earnings results on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The company had revenue of $2.62 million during the quarter.

Hedge Funds Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new position in shares of Moolec Science SA (NASDAQ:MLEC) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science at the end of the most recent quarter. 0.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.